MAAT INDEX

CLAIM #16932 · Costco Wholesale Corp (COST) · 2026Q2 earnings call · Mar 5, 2026 · due Aug 30, 2026

I would say we will have a small impact as a result of the change with Medicare and the pricing of the drugs involved there, but nothing that I would call out to think about as a material headwind for us in terms of our top line sales results as we see it today.

Gary Millerchip · CFO

PENDING
graded after results covering Aug 30, 2026 are reported

How to check this claim

Look at: Total company (or pharmacy segment) top-line sales growth rate, as reported

It came true if: No disclosed material deceleration attributed to Medicare drug pricing changes; total revenue growth remains consistent with prior trend (not a drop framed by management as a material headwind)

Where: Company quarterly earnings release and management commentary on subsequent earnings calls (10-Q/10-K and call transcripts)

In context

ur pharmacy business. I think you've heard us say on a couple of the previous earnings calls that the team is really focused on how do we make sure that we're delivering not just the great value that we always promise to our members, but improving the member experience too. So we've added some new AI tools to improve our in-stock positions on pharmacy, and we've also made some digital enhancements to make it easier for the member to check out at the pharmacy to speed up the experience there as well. So we've seen strong growth in pharmacy. And you may have heard me say in the prepared remarks that the pharmacy business grew at a faster pace than our total sales, which was part of the sort of reason for the disconnect between the core-on-core margin improvement and the core margin overall. I would say we will have a small impact as a result of the change with Medicare and the pricing of the drugs involved there, but nothing that I would call out to think about as a material headwind for us in terms of our top line sales results as we see it today. And I think on retail media, I think really -- we do think it's a significant opportunity, Kelly. But the reason we don't really size it is that it really comes back to my final point that there's tremendous opportunity for us to capture more value, we think, and to help our suppliers actually improve the return on their ad spend. But our focus will be very much on how do we use those dollars to deliver more value back to the member and drive top line sales. So sizing it for us would be more how much value can we create for the member and drive greater investment in our members in the value that we offer. And you would see it more in our top line growth as we're able to achieve that growth versus it being sort of a major change in our margin profile, I would say. Operator: And our final q

Verify independently

SEC filings for COST · Claim quote is verbatim from the 2026Q2 earnings call.